LP

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

Retrieved on: 
수요일, 4월 17, 2024

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=21369 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=21369 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Silvercrest Expands International and Global Equity Capability With Rehan Chaudhri, James A. Dunn, Jr., Ken Dennig, and Robert Gondolfo

Retrieved on: 
목요일, 5월 2, 2024

The team will expand upon Silvercrest’s comprehensive investment capabilities with their Global Equity Strategy, broadening the firm’s offerings to families and institutional investors.

Key Points: 
  • The team will expand upon Silvercrest’s comprehensive investment capabilities with their Global Equity Strategy, broadening the firm’s offerings to families and institutional investors.
  • Our common values of product excellence, client service, and a strong team orientation makes our decision to join Silvercrest an easy one.
  • We look forward to continuing our dialog with our potential clients and partners worldwide.” Mr. Chaudhri established a dynamic global and international value equity track record since 2020.
  • Mr. Chaudhri joins Silvercrest as a Managing Director and Lead Portfolio Manager for the team’s Global Equity Strategy.

Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon

Retrieved on: 
화요일, 4월 23, 2024

Net proceeds to the Company at closing will be approximately $40 million following the repayment of the existing credit facility, as well as fees and expenses associated with the transaction.

Key Points: 
  • Net proceeds to the Company at closing will be approximately $40 million following the repayment of the existing credit facility, as well as fees and expenses associated with the transaction.
  • The credit facility bears interest at a floating rate based upon the secured overnight financing rate (SOFR), plus a margin of 6.75% per annum.
  • There is no warrant coverage to the lenders and no financial covenants associated with the financing.
  • Pharmakon Advisors, LP is a leading investor in non-dilutive debt for the life sciences industry and is the investment manager of the BioPharma Credit funds.

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation – COCH

Retrieved on: 
월요일, 4월 22, 2024

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=21369 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=21369 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Alpine Income Property Trust Reports First Quarter 2024 Operating Results

Retrieved on: 
목요일, 4월 18, 2024

As of March 31, 2024, the Company held a 91.8% interest in Alpine Income Property OP, LP, the Company’s operating partnership (the “Operating Partnership” or “OP”).

Key Points: 
  • As of March 31, 2024, the Company held a 91.8% interest in Alpine Income Property OP, LP, the Company’s operating partnership (the “Operating Partnership” or “OP”).
  • As of March 31, 2024, the Company’s net debt to total enterprise value was 53.9%.
  • On February 20, 2024, the Company announced a cash dividend for the first quarter of 2024 of $0.275 per share, payable on March 28, 2024 to stockholders of record as of the close of business on March 14, 2024.
  • The first quarter 2024 cash dividend represents a payout ratio of 67.1% and 65.5% of the Company’s first quarter 2024 FFO per diluted share and AFFO per diluted share, respectively.

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation – COCH

Retrieved on: 
목요일, 4월 18, 2024

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=21369 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=21369 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation – COCH

Retrieved on: 
월요일, 4월 15, 2024

The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

Key Points: 
  • The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=21369 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Introducing KittenWifHat: The Next Big Solana Project SPL Token

Retrieved on: 
금요일, 4월 12, 2024

we are excited to introduce KittenWifHat (KITTENWIF), a new, community-driven coin that's gearing up to be the next major success on the Solana blockchain.

Key Points: 
  • we are excited to introduce KittenWifHat (KITTENWIF), a new, community-driven coin that's gearing up to be the next major success on the Solana blockchain.
  • Our project draws on the experience of the same team behind Baby BNB, which saw staggering growth from its price, skyrocketing to $22M.
  • Our team is committed to transparency and security, being the first Solana project to receive a full suite of PinkSale badges: Doxxed team, SAFU, KYC, Audit, and AMA sessions.
  • Liquidity is a priority for us; 60% of LP tokens are locked for one year to stabilize and secure our market presence.

Alvara’s ERC-7621 Token Standard Recognized by Ethereum Foundation

Retrieved on: 
금요일, 4월 12, 2024

Basket Token Standard (BTS): A revolutionary approach allowing the creation of tokens that include various underlying ERC-20 tokens.

Key Points: 
  • Basket Token Standard (BTS): A revolutionary approach allowing the creation of tokens that include various underlying ERC-20 tokens.
  • Transferability and Liquidity: By integrating with the ERC-7621 standard for ownership representation, BTS tokens become transferable, enhancing liquidity and management rights.
  • "Recognition of the ERC-7621 standard by the Ethereum Foundation marks a watershed moment for decentralized finance,” said Dominic Ryder Co-founder of Alvara Protocol.
  • Its official recognition by the Ethereum Foundation underscores its importance in the blockchain community.

Novocure Secures New $400 Million Multi-Tranche Non-Dilutive Debt Financing from Pharmakon

Retrieved on: 
목요일, 5월 2, 2024

Novocure (NASDAQ: NVCR) announced today that it has entered into a new five-year up to $400 million committed senior secured credit facility with funds managed by Pharmakon Advisors, LP.

Key Points: 
  • Novocure (NASDAQ: NVCR) announced today that it has entered into a new five-year up to $400 million committed senior secured credit facility with funds managed by Pharmakon Advisors, LP.
  • The committed capital will be available to Novocure in four tranches of $100 million.
  • The first $100 million was issued at closing, and the second $100 million will be issued by June 30, 2025.
  • An additional $200 million is available to be drawn across two tranches, at Novocure’s discretion and subject to certain milestones, through March 31, 2026.